Michael A. Mussallem, Chairman & CEO at Edwards Lifesciences Corp (EW), sold 49,250 shares at $78.09 ($3.1M) on 2023-01-13, disclosed to the SEC on 2023-01-13.
Seasonal sale ($3.1M) by Chairman & CEO — this insider has traded EW in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,500 | $0 | 0.0% |
| 2 | $78.09 | 19,875 | $1.6M | 50.0% |
| 3 | $78.09 | 19,875 | $1.6M | 50.0% |
| Total | $63.03 avg | 49,250 | $3.1M | 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |